| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -98.73% | - | - | 92.63K | ||
| -2.10% | -6.34% | +44.77% | +157.46% | 1,054B | ||
| -1.94% | -5.18% | +61.59% | +58.50% | 621B | ||
| -0.96% | -3.69% | +28.06% | +80.32% | 438B | ||
| -1.12% | -3.68% | +26.89% | +20.58% | 325B | ||
| -1.73% | -3.45% | +26.95% | +44.09% | 281B | ||
| -1.95% | -13.92% | +15.96% | +19.76% | 262B | ||
| -1.45% | -2.37% | -27.87% | -39.87% | 219B | ||
| -0.91% | -3.06% | +20.14% | +56.90% | 195B | ||
| -0.37% | -4.19% | +16.56% | +69.26% | 163B | ||
| Average | -1.30% | -1.70% | +23.67% | +51.89% | 395.13B | |
| Weighted average by Cap. | -1.66% | -1.69% | +33.37% | +77.42% |
Employees
4
Sector
Pharmaceuticals
















